Evidence map›Paper›PMID 19715692›Full record

ArticleExperimental cell research2010

DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells.

Saswati Banerjee, Methode Bacanamwo

Abstract read
In one paragraph

Article in Experimental cell research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 50 citations in OpenAlex.

  1. Modeling DNA methyltransferase function to predict epigenetic correlation patterns in healthy and cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Epigenetic landscape of pluripotent stem cells.Antioxidants & redox signaling · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Saswati BanerjeeCardiovascular Research Institute, Morehouse school of Medicine, 720 Westview Drive, Atlanta, GA 30310, USA.
Methode Bacanamwo
Morehouse School of Medicine · US

Funding

TRANSCRIPTION FACTORS AND PROSTATE CANCERG12RR003034 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI ZHAO, XUEYING · 1986 to 2011
$32.4M
ENHANCEMENT OF CARDIOVASCULAR AND RELATED RESEARCH AREASUH1HL003676 · NHLBI · MOREHOUSE SCHOOL OF MEDICINE · PI GIBBONS, GARY HUGH · 1996 to 2004
$5.3M
MSM Cardiovascular Center of ExcellenceR25HL003676 · NHLBI · MOREHOUSE SCHOOL OF MEDICINE · PI GIBBONS, GARY H · 2005 to 2009
$3.7M
Role of Epigenetics in the Regulation of Blood PressureK01HL084725 · NHLBI · MOREHOUSE SCHOOL OF MEDICINE · PI BACANAMWO, METHODE · 2008 to 2012
$674k
NCRR NIH HHS G12 RR003034NCRR NIH HHS G12-RR03034NHLBI NIH HHS 5 K01 HL084725-02NHLBI NIH HHS 5R25HL003676NHLBI NIH HHS K01 HL084725NHLBI NIH HHS R25 HL003676NHLBI NIH HHS UH1 HL003676
6 · The paper itself

Abstract

Understanding endothelial cell (EC) differentiation is a step forward in tissue engineering, controlling angiogenesis, and endothelial dysfunction. We hypothesized that epigenetic activation of EC lineage specification genes is an important mediator of embryonic stem cell (ESC) differentiation into EC. Mouse ESC was differentiated by removing leukemia inhibitory factor (LIF) from the maintenance media in the presence or absence of the specific DNA methyltransferase (DNMT) inhibitor 5'-aza-2'-deoxycytidine (aza-dC). Expression of EC specification and marker genes was monitored by quantitative PCR, western, immunocytochemistry, and flow cytometry. Functionality of differentiated EC was assessed by angiogenesis assay. The methylation status in the proximal promoter CpGs of the mediators of EC differentiation VEGF-A, BMP4, and EPAS-1 as well as of the mature EC marker VE-cadherin was determined by bisulfite sequencing. ESC differentiation resulted in repression of OCT4 expression in both the absence and presence of aza-dC treatment. However, significant increase in angiogenesis and expression of the mediators of EC differentiation and EC-specific genes was only observed in aza-dC-treated cells. The DNMT inhibition-mediated increase in EC specification and marker gene expression was not associated with demethylation of these genes. These studies suggest that DNMT inhibition is an efficient inducer of EC differentiation from ESC.

Indexed as

Angiopoietin-1AnimalsAntigens, CDAzacitidineBasic Helix-Loop-Helix ProteinsBone Morphogenetic Protein 4Cadherin 5CadherinsCell DifferentiationCell LineCells, CulturedCpG IslandsDecitabineDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesDNA MethylationAngiopoietin-1Angpt1 protein, mouseAntigens, CDAzacitidineBasic Helix-Loop-Helix ProteinsBmp4 protein, mouseBone Morphogenetic Protein 4Cadherin 5CadherinsDecitabineDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesEndothelial PAS Domain-Containing Protein 1Octamer Transcription Factor-3Receptor, TIE-2Vascular Endothelial Growth Factor Avascular endothelial growth factor A, mousevon Willebrand Factor

Identifiers

PMID19715692
PMCPMC2788076
OpenAlexW2095062235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.